RTTNews | Dec 3, 2021 08:03AM EST

08:03 Friday, December 3, 2021 (RTTNews) - I-Mab Says First Two Patients Dosed In U.S. Phase 2 Trial Of Uliledlimab - Atezolizumab On Solid Tumors

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved